Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.
Entact Bio has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2026.
Entact Bio's investors include Janus Henderson Investors, Abingworth, 4BIO Capital, Brandon Capital, Qiming Venture Partners USA.
Entact Bio is headquartered in Watertown, United States.
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.
Entact Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Entact Bio — Funding & Investors." VCBacked, June 3, 2026, https://www.vcbacked.co/company/entact-bio. Accessed August 14, 2026.
VCBacked. (2026). Entact Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/entact-bio
{{cite web |title=Entact Bio — Funding & Investors |url=https://www.vcbacked.co/company/entact-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated